The Balance Recovery Confidence (Brc) Scale
Launched by NECMETTIN ERBAKAN UNIVERSITY · Jun 4, 2024
Trial Information
Current as of February 08, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Balance Restoration Self-Confidence Scale (BRC) to see how well it works for older adults in Turkey. The BRC helps assess how confident people feel about their balance, which is important because falls can lead to serious injuries and health problems for older individuals. The researchers want to make sure that the Turkish version of this scale is accurate and reliable for use in the community, especially for those who may have experienced falls in the past year.
To participate in this study, you need to be 65 years or older, able to read and understand Turkish, and have had at least one fall or a near fall in the last 12 months. You should also be able to walk independently, either with or without a walking aid, and pass some basic tests that check your walking ability and reaction time. If you qualify, you will help researchers understand how well this balance scale works, which could ultimately help improve fall prevention strategies for older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 65 years or older
- • Being literate in Turkish
- • Having at least one near fall or a history of falling in the last 12 months
- • Living independently in the community, with or without the use of a walking aid
- • Not having enough cognitive dysfunction to score 24 or less on the SMM test
- • Being able to walk 6 meters in 12 seconds in the ZKYT test
- • Having the hand reaction to grasp a 30 cm ruler with both hands
- Exclusion Criteria:
- • Walking around the house with the physical assistance of another person.
- • Known active malignant conditions
- • Cardiovascular conditions such as neural syncope, cardiac syncope, structural heart diseases such as aortic stenosis, or hospitalization due to myocardial infarction or heart surgery within the last three months
- • Lung disorders such as chronic severe obstructive pulmonary disease or oxygen dependence,
- • Musculoskeletal disorders such as moderate to severe osteoarthritis, which can affect balance control and muscle function; for example, self-reported trunk and extremity pain or dysfunction, fractures or injuries to the extremities in the past six months
- • Neurological conditions such as Parkinson's Disease, sequelae of stroke, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, severe Dementia or epilepsy
- • Legal blindness, severe visual impairment, severe hearing impairment or legal deafness
Trial Officials
abdulkadir dağbaşı
Principal Investigator
Necmettin Erbakan University
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0